• Advent of the EB-5 broker dealer

    Non-compliance within the EB-5 program can result in enforcement actions from the SEC. See how working with a broker dealer can help you remain in compliance.
  • Life sciences M&A update: H1-2017

    Baker Tilly Capital, LLC's life sciences M&A newsletter provides an overview of the U.S. medical devices and products, pharmaceutical (pharma) and pharma outsourced services sectors, including recent performance and M&A trends.
  • Healthcare M&A update: Q2-2017

    The second quarter of 2017 showed positive performance for the broader U.S. equity market, as the S&P, DJIA and NASDAQ closed up 2.6 percent, 3.3 percent and 3.9 percent, respectively, for the quarter.
  • Great Lakes regional M&A update: Q2-2017

    Middle-market M&A transactions in the Great Lakes region experienced a decrease in the total amount of deal volume, but an increase in aggregate deal value during the second quarter of 2017.